China Healthwise Holdings Limited provided unaudited consolidated group earnings guidance for the half year of 2022. For the period, the group expects to record a loss attributable to owners of the Company within a range of approximately HKD 15 million to approximately HKD 23 million, as compared to a profit attributable to owners of the Company of HKD 37 million for the half year of 2021.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.082 HKD | -21.90% | +15.38% | +156.10% |
Mar. 26 | China Healthwise Holdings Limited Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Mar. 21 | China Healthwise to Widen Losses in 2023 | MT |
1st Jan change | Capi. | |
---|---|---|
+156.10% | 13.9M | |
+19.79% | 72.78B | |
-2.74% | 24.24B | |
+8.80% | 8.59B | |
+9.15% | 8.38B | |
-17.39% | 8.09B | |
+7.33% | 4.81B | |
+17.69% | 4.32B | |
-3.66% | 4.05B | |
-2.54% | 3.93B |
- Stock Market
- Equities
- 348 Stock
- News China Healthwise Holdings Limited
- China Healthwise Holdings Limited Provides Unaudited Consolidated Group Earnings Guidance for the Half Year of 2022